Quantcast

Latest HPV-positive oropharyngeal cancer Stories

2014-08-20 08:27:55

SAN DIEGO, Aug. 20, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced today that results from two clinical studies will be presented at the 29th International Papillomavirus (IPV) conference for the Company's urine-based diagnostic test for the detection of high risk strains of Human Papillomavirus (HPV). The IPV conference is scheduled to take place in Seattle from August 21(st) to 25(th). Additionally, a new U.S. patent...

2014-08-01 10:35:50

Johns Hopkins Medicine Physicians at Johns Hopkins have developed blood and saliva tests that help accurately predict recurrences of HPV-linked oral cancers in a substantial number of patients. The tests screen for DNA fragments of the human papillomavirus (HPV) shed from cancer cells lingering in the mouth or other parts of the body. A description of the development is published in the July 31 issue of JAMA Otolaryngology – Head & Neck Surgery. "There is a window of opportunity...

Human Papilloma Virus
2014-05-21 06:35:26

April Flowers for redOrbit.com - Your Universe Online There are currently 148 known strains of the human papillomavirus (HPV), and a new study led by NYU Langone Medical Center reveals that 69 percent of otherwise healthy US adults are infected with one or more strains. The findings, presented at the 2014 American Society for Microbiology Meeting, are derived from what is believed to be the largest and most detailed genetic analysis of its kind. The analysis showed that, out of the 103...

2014-04-09 11:41:42

Results from the study could help determine potential treatment options A quartet of proteins that play critical roles in cell replication, cell death, and DNA repair could lead to better targets for therapy against treatment-resistant head-and-neck squamous cell cancers. In a study to be presented at the AACR Annual Meeting 2014 on Tuesday, April 8, Ranee Mehra, MD, a medical oncologist who specializes in head and neck cancers at Fox Chase Cancer Center, and colleagues, showed a...

2014-04-07 15:53:35

Patients with cancer of the throat and who are positive for the Human Papilloma virus (HPV+) have a good prognosis, but until now the effect of being HPV+ on the prognosis of tumors located elsewhere in the head and neck was unknown. Danish researchers have now shown that HPV status appears to have no prognostic effect on the outcome of primary radiotherapy in head and neck cancer outside the oropharynx (the part of the throat located behind the mouth, and which contains the soft palate and...

2014-04-02 08:32:24

Xpert HPV is the Only Test Capable of Reporting High-risk Human Papillomavirus DNA in Captured Cervical Cells SUNNYVALE, Calif., April 2, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced the release of Xpert(®) HPV, a 60-minute test for cervical cancer-related human papillomaviruses to be marketed as a CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices. The test runs on Cepheid's GeneXpert(®) System, the world's leading molecular diagnostic...

2013-07-24 23:24:48

A new study, published in the Journal of Clinical Oncology on June 17, 2013 showed that 33% of all throat cancer cases may be caused by HPV infection. (1) polyDNA recommends Gene-Eden-VIR, a natural antiviral supplement, against the latent HPV. Rochester, NY (PRWEB) July 24, 2013 HPV is a much more common cause of throat cancer than originally thought, and it is spreading. Last month, actor Michael Douglas made headlines when he “told a British newspaper that his throat cancer had come...

Inexpensive Blood Test Reveals HPV Presence, Potential Cancer Risk
2013-06-18 18:30:30

Brett Smith for redOrbit.com — Your Universe Online Earlier this month, actor Michael Douglas raised the prospect of oral sex leading to throat cancer through the transmission of the human papillomavirus (HPV), a virus known to cause the disease in some individuals. According to a new study from a team of international researchers in the Journal of Clinical Oncology, blood tests can be used to detect the presence of the virus via the body´s production of telltale antibodies...

2013-03-31 23:02:55

polyDNA will be lowering the price of Gene-Eden-VIR by 50% for those suffering from oral cancer during Oral Cancer Awareness Month. Rochester, NY (PRWEB) March 31, 2013 polyDNA is a leading developer of natural HPV remedies. As the Washington Times noted, ““¦(HPV) is the second leading cause of oral cancer.”[1] During the month of April, which has been sponsored by the Oral Cancer Foundation as Oral Cancer Awareness Month, polyDNA will be lowering the price of...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.